NCT05014204View on ClinicalTrials.gov

Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 29, 2021

Primary Completion Date

May 26, 2024

Study Completion Date

March 31, 2025

Conditions
DiabetesDiabetes Type 2Diabetes Mellitus, Type 2Glucose Metabolism DisordersMetabolic DiseaseEndocrine System DiseasesDiabetes Mellitus
Interventions
DEVICE

The Endogenex Device

The Endogenex device is designed to induce duodenal mucosal regeneration using pulsed electric field. The Endogenex procedure is a non-surgical, endoscopic procedure.

Trial Locations (3)

55905

Mayo Clinic, Rochester

56441

Cuyuna Regional Medical Center, Crosby

90033

University of Southern California, Los Angeles

Sponsors

Lead Sponsor

Endogenex, Inc.
All Listed Sponsors
lead

Endogenex, Inc.

INDUSTRY